- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Beijing Tiantan Biological Products Corp Ltd (600161)
Assess today's live Beijing Tiantan Biological Products Corp Ltd (600161) share price, performance and insights using our live Shanghai: 600161 stock exchange data.
Analyse the historical data and Beijing Tiantan Biological Products Corp Ltd share price performance charts on this page. Our technical summary section provides analysis on Beijing Tiantan Bio share price buy/sell indicators using real-time data (or discuss the Beijing Tiantan Bio (600161) stock price today with other investors in the Beijing Tiantan Bio SS share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current SS 600161 share price (ISIN: CNE000000WF9) to enhance your trading decisions with our free investment tools and resources.
What Is the Beijing Tiantan Biological Products Corp Ltd Share Price Today?
The Beijing Tiantan Bio share price today is 16.30.
What Is the Stock Symbol for Beijing Tiantan Biological Products Corp Ltd
The stock symbol (or 'ticker') for Beijing Tiantan Biological Products Corp Ltd is "600161."
What Stock Exchange Does Beijing Tiantan Biological Products Corp Ltd Trade On?
Beijing Tiantan Biological Products Corp Ltd is listed and trades on the Shanghai stock exchange.
Is Beijing Tiantan Biological Products Corp Ltd a Good Stock to Buy?
Determining whether Beijing Tiantan Biological Products Corp Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Beijing Tiantan Biological Products Corp Ltd share price performance charts on this page. Our technical summary section provides analysis on Beijing Tiantan Bio share price buy/sell indicators using real-time data (or discuss the Beijing Tiantan Bio (600161) stock price today with other investors in the Beijing Tiantan Bio SS share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current SS 600161 share price (ISIN: CNE000000WF9) to enhance your trading decisions with our free investment tools and resources.
What Is the Beijing Tiantan Biological Products Corp Ltd Share Price Today?
The Beijing Tiantan Bio share price today is 16.30.
What Is the Stock Symbol for Beijing Tiantan Biological Products Corp Ltd
The stock symbol (or 'ticker') for Beijing Tiantan Biological Products Corp Ltd is "600161."
What Stock Exchange Does Beijing Tiantan Biological Products Corp Ltd Trade On?
Beijing Tiantan Biological Products Corp Ltd is listed and trades on the Shanghai stock exchange.
Is Beijing Tiantan Biological Products Corp Ltd a Good Stock to Buy?
Determining whether Beijing Tiantan Biological Products Corp Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Shanghai
Currency in CNY
16.30
-0.04(-0.24%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.25
16.42
52 wk Range
16.06
23.61
600161 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.2516.42
52 wk Range
16.0623.61
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.53%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.53%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
600161 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
24.36
Upside
+49.42%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high P/E ratio relative to near-term earnings growth
- Tiantan Bio receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Tiantan Bio receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Beijing Tiantan Bio Company Profile
Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationlly. Its products include human albumin; intravenous human immunoglobulin; rabies patient immunoglobulin; tetanus human immunoglobulin; hepatitis B human immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamine human immunoglobulin; human prothrombin complex; human coagulation factors VIII; human fibrinogen; recombinant human coagulation factor VIII for injection; and other blood products. The company was founded in 1966 and is headquartered in Beijing, China.
Compare 600161 to Peers and Sector
Metrics to compare | 600161 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600161PeersSector | |
|---|---|---|---|---|
P/E Ratio | 24.5x | 30.6x | −0.5x | |
PEG Ratio | 7.97 | −1.14 | 0.00 | |
Price/Book | 2.8x | 2.5x | 2.6x | |
Price / LTM Sales | 5.0x | 6.6x | 3.3x | |
Upside (Analyst Target) | 50.3% | 23.3% | 47.0% | |
Fair Value Upside | Unlock | 11.0% | 5.9% | Unlock |
Analyst Ratings
5 Buy
2 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 24.36
(+49.42% Upside)
Earnings
Latest Release
Oct 24, 2025
EPS / Forecast
0.09 / 0.1975
Revenue / Forecast
1.35B / 1.40B
People Also Watch
FAQ
What Is the Beijing Tiantan Bio (600161) Share Price Today?
The live Beijing Tiantan Bio share price today is 16.30
What Stock Exchange Does Beijing Tiantan Bio (600161) Trade On?
Beijing Tiantan Bio is listed and trades on the Shanghai Stock Exchange.
What Is the Ticker (Stock Symbol) for Beijing Tiantan Bio?
The stock symbol (also called a 'ticker') for Beijing Tiantan Bio is "600161."
Does Beijing Tiantan Bio Pay Dividends? What’s The Current 600161 Dividend Yield?
Yes, 600161 Pays Dividends to its Shareholders. The current Beijing Tiantan Bio dividend yield is 1.53%.
What Is the Current Beijing Tiantan Bio Market Cap?
As of today, Beijing Tiantan Bio market capitalisation is 32.23B.
What Is Beijing Tiantan Bio's (600161) Earnings Per Share (TTM)?
The Beijing Tiantan Bio EPS is currently 0.66 (Trailing Twelve Months).
When Is the Next Beijing Tiantan Bio Earnings Date?
Beijing Tiantan Bio's next earnings report will be released on 28/03/2026.
Is 600161 a Buy or Sell From a Technical Analyst Perspective?
Based on today's Beijing Tiantan Bio moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Beijing Tiantan Bio Stock Split?
Beijing Tiantan Bio has split 9 times. (See the 600161 stock split history page for full effective split date and price information.)
How Many Employees Does Beijing Tiantan Bio Have?
Beijing Tiantan Bio has 5298 employees.
What is the current trading status of Beijing Tiantan Bio (600161)?
As of 16 Feb 2026, Beijing Tiantan Bio (600161) is trading at a price of 16.30, with a previous close of 16.34. The stock has fluctuated within a day range of 16.25 to 16.42, while its 52-week range spans from 16.06 to 23.61.
What Is Beijing Tiantan Bio (600161) Price Target According to Analysts?
The average 12-month price target for Beijing Tiantan Bio is CNY24.36, with a high estimate of CNY25.82 and a low estimate of CNY22.6. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +49.42% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.